Impact of Anti-Tuberculosis Drug Use on Treatment Outcomes in Patients with Pulmonary Fluoroquinolone-Resistant Multidrug-Resistant Tuberculosis: A Nationwide Retrospective Cohort Study with Propensity Score Matching

BACKGROUND: Effective treatment of fluoroquinolone-resistant multidrug-resistant tuberculosis (FQr-MDR-TB) is difficult because of the limited number of available core anti-TB drugs and high rates of resistance to anti-TB drugs other than FQs. However, few studies have examined anti-TB drugs that ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Hongjo, Jeong, Dawoon, Kang, Young Ae, Jeon, Doosoo, Kang, Hee-Yeon, Kim, Hee Jin, Kim, Hee-Sun, Mok, Jeongha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Tuberculosis and Respiratory Diseases 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10323203/
https://www.ncbi.nlm.nih.gov/pubmed/37254489
http://dx.doi.org/10.4046/trd.2023.0040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10323203/
https://www.ncbi.nlm.nih.gov/pubmed/37254489
http://dx.doi.org/10.4046/trd.2023.0040

Ejemplares similares